Subscribe to our newsletter

SPHERES: Neuromyelitis Optica Spectrum Disorder (NMOSD) Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
+
STUDY VISITS
+
PATIENTS
20 +
SITES
+
PROVIDERS
+
STATES

Outcome measures in the CorEvitas NMOSD Registry

Among the variables we collect, some of the key outcome measures to inform your research include:

Disease Characteristics

Patient Reported Outcomes

Contact the SPHERES Registry Team:

Registry Scientific Advisors

Michael Levy, MD, PhD

Michael Levy, MD, PhD

Associate Professor, Harvard Medical School | Director, The NMO Clinic and Research Laboratory | Research Director, Division of Neuroimmunology & Neuroinfectious Disease, Massachusetts General Hospital

Jeffrey Bennett, MD, PhD

Jeffrey Bennett, MD, PhD

Professor of Neurology and Ophthalmology, Neuroscience University of Colorado School of Medicine (UCSOM) | Clinician, UCHealth